Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.49 |
| ▸ | POLB | P06746 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 12/20 | 0.48 |
| ▸ | MGAM | O43451 | 10/20 | 0.48 |
| ▸ | SI | P14410 | 10/20 | 0.48 |
| ▸ | MGAM2 | Q2M2H8 | 10/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | KDM4A | O75164 | 1/20 | 0.48 |
| ▸ | KDM4B | O94953 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.48 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.48 |
| ▸ | ALKBH3 | Q96Q83 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20830286 | 0.82 | KDM4E (0.55) | MAPTPOLBGAAKDM4EL3MBTL1 | |
| SCHEMBL20819246 | 0.81 | KDM4E (0.50) | MAPTPOLBGAAKDM4EL3MBTL1 | |
| SCHEMBL22487780 | 0.81 | ALKBH3 (0.56) | MAPTPOLBGAAKDM4EL3MBTL1 | |
| SCHEMBL20830285 | 0.81 | KDM4E (0.53) | MAPTPOLBGAAKDM4EL3MBTL1 | |
| SCHEMBL20819201 | 0.80 | KDM4E (0.55) | MAPTPOLBGAAKDM4EL3MBTL1 | |
| SCHEMBL20830289 | 0.79 | ABL1 (0.58) | MAPTPOLBGAAKDM4EL3MBTL1 | |
| SCHEMBL22487734 | 0.79 | KDM4E (0.52) | MAPTPOLBGAAKDM4EL3MBTL1 | |
| SCHEMBL20830305 | 0.78 | KDM4E (0.55) | MAPTPOLBGAAKDM4EL3MBTL1 | |
| SCHEMBL20830302 | 0.78 | KDM4E (0.55) | MAPTPOLBGAAKDM4EL3MBTL1 | |
| SCHEMBL20819222 | 0.78 | KDM4E (0.59) | MAPTPOLBGAAKDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200308165-A1 | Compounds as Ras Inhibitors and Use Thereof | D. E. SHAW RESEARCH, LLC | 2020-10-01 | — | — | US | disclosed |
| US-20200308165-A1 | Compounds as Ras Inhibitors and Use Thereof | D. E. SHAW RESEARCH, LLC | 2020-10-01 | — | — | US | disclosed |
| EP-3681499-A1 | COMPOUNDS AS RAS INHIBITORS AND USE THEREOF | D.E. Shaw Research, LLC (US) | 2020-07-22 | — | — | EP | disclosed |
| WO-2019055540-A1 | COMPOUNDS AS RAS INHIBITORS AND USE THEREOF | D.E. SHAW RESEARCH, LLC (US) | 2019-03-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200308165-A1 | Compounds as Ras Inhibitors and Use Thereof | KRAS, NRAS, HRAS | MAPT 3664/4885POLB 3205/4885GAA 598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.